Publications by authors named "Yacine N Sow"

In 2023-2024, a resolution was proposed to "sunset" the American Academy of Dermatology's Diversity, Equity, and Inclusion initiatives, citing concerns about stifling diversity of thought and promoting antisemitism. Although this resolution was ultimately withdrawn, there are many ethical issues surrounding this complex issue. Herein, we explore ways in which Diversity, Equity, and Inclusion and the fight against antisemitism are not only compatible but synergistic.

View Article and Find Full Text PDF

Background: Central centrifugal cicatricial alopecia (CCCA) nomenclature describes a typical clinical presentation of cicatricial hair loss that begins on the vertex scalp with progressive, symmetric, and centrifugal evolution. However, atypical presentations have been noted clinically by the authors and reported in the literature.

Objective: We sought to characterize the distribution of hair loss in published cases of adult patients with CCCA.

View Article and Find Full Text PDF

Orofacial granulomatosis is a rare disorder that is heterogeneously defined in the published literature. Herein, we describe a patient with orofacial granulomatosis with clinical and histologic evidence, discuss differential diagnoses, and offer clinical pearls for diagnosing and assessing this disorder. Our case provides support that orofacial granulomatosis is a distinct disorder as opposed to a sequela of other systemic granulomatous diseases.

View Article and Find Full Text PDF

Background: Black haircare is an estimated $2.51-billion-dollar industry. Black women spend 9 times more on ethnic hair products than non-Black consumers.

View Article and Find Full Text PDF
Article Synopsis
  • The study highlights that despite the FDA's approval of adalimumab for hidradenitis suppurativa (HS), many patients do not obtain prescriptions, indicating a disconnect between guidelines and actual practice.
  • The research focused on understanding the decision-making factors for patients considering biologic therapies, utilizing open-ended interviews with participants suffering from HS.
  • Key factors influencing treatment decisions included perceptions of treatment risks, treatment fatigue, individual understanding of the disease, and information sources, emphasizing the need for improved education and communication between patients and healthcare providers.
View Article and Find Full Text PDF